These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 152484)

  • 1. Biochemical aspects of the interactions of the teratogens 5-fluorouracil and 5-fluorodeoxyuridine with normal nucleic acid precursors in mice selected for low and high expression of Strong's luxoid gene.
    Forsthoefel PF; Blend MJ; Snow JW
    Teratology; 1978 Oct; 18(2):269-76. PubMed ID: 152484
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of 5-fluorouracil and 5-fluorodeoxyuridine used alone and in combination with normal nucleic acid precursors on development of mice in lines selected for low and high expression of Strong's luxoid gene.
    Forsthoefel PF; Williams ML
    Teratology; 1975 Feb; 11(1):1-13. PubMed ID: 124471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects on mouse development of interactions of 5-fluorouracil with Strong's luxoid gene and its plus and minus modifiers.
    Forsthoefel PF
    Teratology; 1972 Aug; 6(1):5-17. PubMed ID: 4626856
    [No Abstract]   [Full Text] [Related]  

  • 4. Some aspects of the role of vitamin B12 in nucleic acid synthesis in a neoplastic C3H mouse cell strain. II. Incorporation of precursors.
    Rotherham J; Price FM; Evans VJ
    J Natl Cancer Inst; 1970 Jan; 44(1):91-7. PubMed ID: 11515040
    [No Abstract]   [Full Text] [Related]  

  • 5. Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.
    Washtien WL; Santi DV
    Cancer Res; 1979 Sep; 39(9):3397-404. PubMed ID: 157805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the teratogenic effects of 5-fluorouracil by natural pyrimidines. II. Biochemical aspects.
    Schumacher HJ; Wilson JG; Jordan RL
    Teratology; 1969 May; 2(2):99-105. PubMed ID: 5790158
    [No Abstract]   [Full Text] [Related]  

  • 7. Selectivity of action of 5-FU: biochemical basis.
    Rustum YM; Danhauser L; Wang G
    Bull Cancer; 1979; 66(1):43-7. PubMed ID: 154352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of thymidine after administration of fluorouracil and fluorouridine to adult and embryo mice.
    Williams JP
    Res Commun Chem Pathol Pharmacol; 1971 Nov; 2(6):859-68. PubMed ID: 4264748
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells.
    Maybaum J; Ullman B; Mandel HG; Day JL; Sadee W
    Cancer Res; 1980 Nov; 40(11):4209-15. PubMed ID: 6451283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil incorporation in DNA of human breast carcinoma cells.
    Major PP; Egan E; Herrick D; Kufe DW
    Cancer Res; 1982 Aug; 42(8):3005-9. PubMed ID: 6212116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo.
    Sawyer RC; Stolfi RL; Martin DS; Spiegelman S
    Cancer Res; 1984 May; 44(5):1847-51. PubMed ID: 6713387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL; Fischer PH
    Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incorporation of labelled precursors into the DNA and nuclear proteins of bone marrow cells at different times of day normally and on the administration of hydrocortisone].
    Revich GG; Savina MI
    Probl Gematol Pereliv Krovi; 1980 Feb; 25(2):29-32. PubMed ID: 7360744
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzymatic determinants of responsiveness of the LPC-1 plasma cell neoplasm to fluorouracil and fluorodeoxyuridine.
    Everson R; Kessel D; Hall TC
    Biochem Pharmacol; 1970 Nov; 19(11):2932-4. PubMed ID: 4254308
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nucleic acid metabolism in hepatoma 46 and normal liver].
    Bogdanov GN; Shmonina VM
    Ukr Biokhim Zh; 1974; 46(2):181-4. PubMed ID: 4363993
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of thymidine and thymidine plus 5-fluorouracil on the growth kinetics of a human lymphoid cell line.
    Murgo AJ; Fried J; Burchenal D; Vale KL; Strife A; Woodcock T; Young CW; Clarkson BD
    Cancer Res; 1980 May; 40(5):1543-9. PubMed ID: 6445227
    [No Abstract]   [Full Text] [Related]  

  • 18. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
    Ingraham HA; Tseng BY; Goulian M
    Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydactyly in the Strong's luxoid mouse is suppressed by limb deformity alleles.
    Vogt TF; Leder P
    Dev Genet; 1996; 19(1):33-42. PubMed ID: 8792607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
    Chadwick M; Rogers WI
    Cancer Res; 1972 May; 32(5):1045-56. PubMed ID: 4259631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.